Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 9.010M
March 31, 2026 9.213M
December 31, 2025 9.401M
September 30, 2025 9.374M
June 30, 2025 9.430M
March 31, 2025 10.07M
December 31, 2024 10.07M
September 30, 2024 10.09M
June 30, 2024 10.12M
March 31, 2024 10.12M
December 31, 2023 10.09M
September 30, 2023 10.12M
June 30, 2023 10.16M
March 31, 2023 10.17M
December 31, 2022 9.170M
September 30, 2022 10.23M
June 30, 2022 10.26M
March 31, 2022 10.22M
December 31, 2021 10.17M
September 30, 2021 9.329M
June 30, 2021 9.269M
March 31, 2021 9.202M
December 31, 2020 9.177M
September 30, 2020 9.109M
June 30, 2020 9.058M
Date Value
March 31, 2020 9.058M
December 31, 2019 9.042M
September 30, 2019 8.995M
June 30, 2019 8.995M
March 31, 2019 8.965M
December 31, 2018 8.876M
September 30, 2018 8.865M
June 30, 2018 8.802M
March 31, 2018 8.757M
December 31, 2017 8.733M
September 30, 2017 8.717M
June 30, 2017 8.717M
March 31, 2017 8.679M
December 31, 2016 8.669M
September 30, 2016 8.658M
June 30, 2016 8.658M
March 31, 2016 8.612M
December 31, 2015 8.637M
September 30, 2015 8.712M
June 30, 2015 8.726M
March 31, 2015 8.717M
December 31, 2014 8.710M
September 30, 2014 8.709M
June 30, 2014 8.704M
March 31, 2014 8.695M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Olin Corp. 114.00M
Stepan Co. 22.73M
Solesence, Inc. 70.65M
BioLargo, Inc. 325.23M
The Chemours Co. 150.46M